Skip to main content

Animations

MJFF Publications

5651 - 5660 of 6082 Results
Title
Year
  • Year
  • 2012
  • 2012
  • 2012
  • 2012
  • 2012
  • 2012
  • 2012
  • 2012
  • 2012
  • 2012
  • Summary Details
    OPEN
    Title: Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/hmg/dds161
    Citation Count: 223
  • Summary Details
    OPEN
    Title: Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2012.04.025
    Citation Count: 63
  • Summary Details
    OPEN
    Title: Role of Elongation and Secondary Pathways in S6 Amyloid Fibril Growth
    Journal Name: Biophysical Journal
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: elsevier-specific: oa user license
    DOI - Digital Object Identifier: 10.1016/j.bpj.2012.03.047
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182553c5b
    Citation Count: 65
  • Summary Details
    OPEN
    Title: Isocitrate dehydrogenase 1 is downregulated during early skin tumorigenesis which can be inhibited by overexpression of manganese superoxide dismutase
    Journal Name: Cancer Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: unspecified-oa
    DOI - Digital Object Identifier: 10.1111/j.1349-7006.2012.02317.x
    Citation Count: 19
  • Summary Details
    OPEN
    Title: The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's disease
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2012.03.029
    Citation Count: 30
  • Summary Details
    OPEN
    Title: BH3-only proteins are part of a regulatory network that control the sustained signalling of the unfolded protein response sensor IRE1α
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/emboj.2012.84
    Citation Count: 103
  • Summary Details
    OPEN
    Title: A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182516244
    Citation Count: 315
  • Summary Details
    OPEN
    Title: Habitual intake of dietary flavonoids and risk of Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e31824f7fc4
    Citation Count: 309
  • Summary Details
    OPEN
    Title: Network correlates of disease severity in multiple system atrophy
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e318250d7fd
    Citation Count: 55
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.